Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin-Reference-Cited by-同舟云学术

Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin

Published:2012-07 Issue:3 Volume:158 Page:400-404
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Pesaro Antonio Eduardo P.,Serrano Carlos V.,Fernandes Juliano L.,Cavalcanti Alexandre B.,Campos Alexandre H.,Martins Herlon S.,Maranhão Raul C.,de Lemos James A.,Souza Heraldo P.,Nicolau José C.

Funder

São Paulo Research Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial;Lancet,2002

3. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

4. Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines;Grundy;J Am Coll Cardiol,2004

5. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions;Kosoglou;Clin Pharmacokinet,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of High‐Intensity Statins Versus Low/Moderate‐Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL‐C Goals: A Systematic Review and Meta‐Analysis;Clinical Cardiology;2024-08

2. The impact of the 2019 ESC/EAS dyslipidaemia guidelines on real-world initial lipid-lowering therapy in patients with acute myocardial infarction;Medicine;2024-03-22

3. Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia;The Korean Journal of Internal Medicine;2023-11-01

4. Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy;Minerva Cardiology and Angiology;2023-10

5. Understanding the molecular mechanisms of statin pleiotropic effects;Archives of Toxicology;2023-04-21